Enabling the public's early access to good medicines

Porton PharmaTech
Next steps

Porton PharmaTech is a European subsidiary of Porton Pharma Solutions Ltd.

An internationally recognized pharmaceutical contract development and manufacturing organization (CDMO) in drug substance development and manufacturing.

Porton PharmaTech is currently undergoing development, with new constructions and facility enhancements underway.

New facilities include space designated for research and development laboratories and a KILOLAB startup from Q2’24 onwards.

One of the key highlights is the on-going green field investment in a PILOT PLANT designed to host capacity of different unit operations trains, including finalization, QC laboratories and Process Safety Laboratory. The operations are scheduled to start from Q2’25 with qualification of GMP activities by Q1’26.

KILOLAB and R&D LAB startup

Q2

2024

PILOT PLANT

Q1

2026

Qualification of GMP activities

Q1

2026

Our global network

We have 5000+ skilled employees working across 20+ sites around the globe

globe map

NEW JERSEY, USA

R&D & GMP Manufacturing, DS
R&D & GMP Manufacturing, HP & DP

Turnhout, Belgium

Office

Root, Switzerland

Office

Copenhagen, Denmark

Office

Mengeš, slovenia

R&D & GMP Manufacturing, DS

Chongqing, CHINA

Headquarters, R&D, DS
GMP Manufacturing, DS
GMP Manufacturing, DP

Xiaogan, CHINA

Manufacturing, RSM

Yichun, CHINA

GMP Manufacturing, DS

Suzhou, CHINA

R&D & GMP Manufacturing, CGT

Shanghai, CHINA

Headquarters, R&D, DS
R&D, DS
GMP Manufacturing, DS
R&D & GMP Manufacturing, Biologics (mAb & XDC)

1600+

R&D Scientists

2000+

Total Capacity (m3)

800+

Global Customers

Enabling the public's early access to good medicines

About us

A Customer-Centric, Innovative and Reliable CDMO with Global Solutions

molecules

Small Molecules CDMO Services

tides

TIDES CDMO Services

Only at Porton CN

biologics

Biologics CDMO Services

Only at Porton CN

Latest News

Insights Unveiled: Delve into
Our Global News Hub!

Explore job opportunities

 

Cookie settings

Your current status

Show details